Influence of the calcium antagonist amlodipine on left ventricular mass and function in patients with essential hypertension

Clinical Drug Investigation

Volumn 13, Issue SUPPL. 1, 1997, Pages 17-21

  Cerasola, Giovanni ^a,b   Nardi, Emilio ^a   Cottone, Santina ^a   Giuliano, Francesco ^a   Volpe, Vito ^a   Panepinto, Nicolo ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; ANTIHYPERTENSIVE AGENT; CALCIUM ANTAGONIST;

ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL ARTICLE; CLINICAL TRIAL; DIASTOLIC BLOOD PRESSURE; DOPPLER ECHOCARDIOGRAPHY; DRUG EFFECT; ESSENTIAL HYPERTENSION; FEMALE; HEART LEFT VENTRICLE MASS; HEART RATE; HEART VENTRICLE HYPERTROPHY; HUMAN; M MODE ECHOCARDIOGRAPHY; MALE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

EID: 0030852750     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-199700131-00005     Document Type: Article

References (36)

1. Abi-Samra F, Fouad FM, Tarazi RC. Determinants of left ventricular hypertrophy and function in hypertensive patients: an echocardiographic study. Am J Med 1982; 75 Suppl. 3A: 26-31
2. Cerasola G, D'Ignoto G, Cottone S, et al. Blood pressure pattern importance in the development of left ventricular hypertrophy in hypertension. G Ital Cardiol 1991; 21: 389-95
3. Devereux RB, Pickering TG, Harshfiekd GA, et al. Left ventricular hypertrophy in patients with hypertension: importance of blood pressure response to regularly reoccurring stress. Circulation 1983; 68: 470-6
4. Drayer JIM, Weber MA, Gardin JM, et al. Effect of long-term antihypertensive therapy on cardiac anatomy in patients with essential hypertension. Am J Med 1983; 75 Suppl. 3A: 116-20
5. Devereux RB, Pickering TG, Cody RJ, et al. Relation of renin-angiotensin system activity to left ventricular hypertrophy and function in experimental and human hypertension. J Clin Hypertens 1987; 3: 87-103
6. Radice M, Alli C, Avanzini F, et al. Left ventricular structure and function in normotensive adolescents with a genetic predisposition to hypertension. Am Heart J 1986; 111: 115-8
7. Simpson P. Norepinephrine stimulated hypertrophy of cultured rats myocardial cells in an alpha 1 adrenergic response. J Clin Invest 1983; 37: 376-81
8. Cuocolo A, Sax FL, Brush JE, et al. Left ventricular hypertrophy and impaired diastolic filling in essential hypertension. Circulation 1990; 81: 978-86
9. Devereux RB. Left ventricular diastolic dysfunction: early diastolic relaxation and late diastolic compliance. JACC 1989; 13: 337-9
10. Fagard RH. Left ventricular function in essential hypertension. High Blood Press Cardiovasc Prev 1993; 2 Suppl. 1: 5-10
11. Brilla CG, Janicki JS, Weber KT. Impaired diastolic function and coronary reserve in genetic hypertension. Role of interstitial fibrosis and medial thickening of intramyocardial coronary arteries. Circ Res 1991; 69: 107-15
12. Doering CW, Jalil JE, Janicki JS, et al. Collagen network remodelling and diastolic stiffness of the rat left ventricle with pressure overload hypertrophy. Cardiovasc Res 1988; 22: 686-95
13. Douglas PS, Tallant B. Hypertrophy, fibrosis and diastolic dysfunction in early canine experimental hypertension. JACC 1991; 17: 530-6
14. Phillips RS, Goldman ME, Ardeljan M, et al. Determinants of abnormal left ventricular filling in early hypertension. JACC 1989; 14: 979-85
15. Gottdiener JS. Measuring diastolic function. JACC 1991; 18: 83-4
16. Lew WYW. Evaluation of left ventricular diastolic dysfunction. Circulation 1989; 79: 1393-7
17. Marabotti C, Genovesi AE, Palombo C, et al. Echo Doppler assessment of left ventricular filling in borderline hypertension. Am J Hypertens 1989; 2: 891-7
18. Cerasola G, Cottone S, Nardi E, et al. Reversal of cardiac hypertrophy and left ventricular function with the calcium antagonist felodipine in hypertensive patients. J Hum Hypertens 1990; 4: 703-8
19. DeSimone G, Costantino G, Soro S, et al. Effects of nicardipine on left ventricular haemodynamic patterns in systemic hypertension. Am J Hypertens 1989; 2: 139-45
20. Frolich ED. Pathophysiology of hypertension: effects of calcium antagonist on heart and kidney. J Cardiovasc Pharmacol 1989; 13 Suppl. 1: 11-7
21. Motz W, Ploeger M, Ringsgwandl G, et al. Influence of nifedipine on ventricular function and myocardial hypertrophy in spontaneously hypertensive rats. J Cardiovasc Pharmacol 1983; 5: 55-61
22. Wood JJ. Calcium antagonist. Pharmacologic differences and similarities. Circulation 1989; 80 Suppl. IV: IV184-8
23. Saragoca MA, Portela JE, Abreu P, et al. Regression of left ventricular hypertrophy in the short-term treatment of hypertension with isradipine. Am J Hypertens 1991; 4 Suppl.: 188-9OS
24. Devereux RB, Reicheck N. Echocardiographic determination of left ventricular mass in man: anatomic validation of the method. Circulation 1977; 55: 613-8
25. Drayer JIM, Weber MA, de Young JL. Blood pressure as a determinant of cardiac left ventricular muscle mass. Arch Int Med 1983; 143: 90-2
26. Fouad FM, Nakashima Y, Tarazi RC, et al. Reversal of left ventricular hypertrophy in hypertensive patients treated with methyldopa: lack of association with blood pressure control. Am J Cardiol 1982; 49: 785-801
27. Fouad FM, Tarazi RC, Bravo EL. Cardiac and haemodynamic effects of enalapril. J Hypertens 1983; 1 Suppl. 1: 135-40
28. Frishman WH, Skolnick AE, Strom JA. Effects of calcium entry blockade on hypertension-induced left ventricular hypertrophy. Circulation 1989; 80 Suppl. IV: IV151-6I
29. Wollam GL, Hall WD, Porter VD, et al. Time course of regression of left ventricular hypertrophy in treated hypertensive patients. Am J Med 1983; 75 Suppl. 3A: 100-10
30. Dahlof B, Pennert K, Hansson L. Reversal of left ventricular hypertrophy in hypertensive patients. Am Heart J 1992; 5: 95-110
31. Nardi E, Cottone S, D'Ignoto G, et al. La funzione diastolica del ventricolo sinistro nell'ipertensione arteriosa essenziale: ruolo dell'output simpatico. Cardiologia. In press
32. Motz W, Strauer RB. Left ventricular function and collagen content after regression of hypertensive hypertrophy. Hypertension 1989; 13: 43-50
33. Muiesan ML, Agabiti-Rosei E, Romanelli G, et al. Improved left ventricular systolic and diastolic function after regression of cardiac hypertrophy, treatment withdrawal, and redevelopment of hypertension. J Cardiovasc Pharmacol 1991; 17 Suppl. 2: S179-81
34. Shahi M, Thom S, Poulter M, et al. Regression of hypertensive left ventricular hypertrophy and left ventricular diastolic function. Lancet 1990; 336: 458-61
35. Trimarco B, DeLuca N, Rosiello G, et al. Improvement of diastolic function after reversal of left ventricular hypertrophy induced by long-term antihypertensive treatment with tertalol. Am J Cardiol 1989; 64: 745-51
36. Zusman RM, Christensen DM, Federman EB, et al. Nifedipine, but not propranolol, improves left ventricular systolic and diastolic function in patient with hypertension. Am J Cardiol 1989; 64: 51-61F